BMO Capital Downgrades Chemours (CC) to Underperform

Go back to BMO Capital Downgrades Chemours (CC) to Underperform

Chemours Announces Management Actions and Delay of Form 10-K; Provides Preliminary Unaudited 2023 Year-End Results

February 28, 2024 10:14 PM EST

WILMINGTON, Del.--(BUSINESS WIRE)-- The Board of Directors of The Chemours Company (Chemours or the Company) (NYSE: CC) has appointed Denise Dignam as the Interim Chief Executive Officer and Matt Abbott as the Interim Chief Financial Officer (principal financial and accounting officer).

Ms. Dignam joined Chemours in 2015 and has served as our President Titanium Technologies since March 2023 and previously served as our President Advanced Performance Materials from 2021 to 2023. She previously served as Vice President of Global Operations Fluoroproducts, from 2019 to 2021; Global Senior Business Director Fluoropolymers, from 2016 to 2019; and North American Business Director Diversified Technologies and... More